Biotage Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Feb 25 | BuySEK 47,013,515 | Peter von Ehrenheim | Individual | 410,000 | SEK 119.90 | |
17 Jul 24 | BuySEK 575,072 | Scott Carr | Individual | 2,973 | SEK 193.43 |
Insider Trading Volume
Insider Buying: BIOTS insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 528,654 | 0.66% |
General Public | 30,055,311 | 37.5% |
Institutions | 49,465,307 | 61.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,365,330 | SEK 657.5m | 175% | 0.59% | |||
4,634,655 | SEK 478.8m | -0.18% | 0.09% | |||
4,069,328 | SEK 420.4m | 19.7% | 0.06% | |||
3,900,000 | SEK 402.9m | 0% | 0.14% | |||
3,808,712 | SEK 393.4m | 0% | 0.01% | |||
2,787,400 | SEK 287.9m | 0% | no data | |||
2,769,095 | SEK 286.0m | 0% | 0.11% | |||
2,632,894 | SEK 272.0m | 0% | 0.02% | |||
2,207,932 | SEK 228.1m | 0% | no data | |||
2,128,366 | SEK 219.9m | 0.82% | no data | |||
2,035,174 | SEK 210.2m | 0% | 0.09% | |||
985,902 | SEK 101.8m | 1.27% | no data | |||
972,839 | SEK 100.5m | 0% | 0.05% | |||
710,000 | SEK 73.3m | 0% | 0.03% | |||
625,000 | SEK 64.6m | 0% | 1.52% | |||
618,377 | SEK 63.9m | 0% | 0.03% | |||
615,805 | SEK 63.6m | 0% | 0.22% | |||
553,340 | SEK 57.2m | -18.6% | no data | |||
481,816 | SEK 49.8m | 0% | no data | |||
444,536 | SEK 45.9m | 0% | 1.15% | |||
427,300 | SEK 44.1m | 0% | 0.17% | |||
426,000 | SEK 44.0m | 2,560% | no data | |||
419,277 | SEK 43.3m | 0% | 1.65% | |||
412,873 | SEK 42.6m | 0% | 0.01% | |||
402,448 | SEK 41.6m | 0% | 0.05% |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/03/22 22:43 |
End of Day Share Price | 2025/02/25 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotage AB (publ) is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Samuel England | Berenberg |
Odysseas Manesiotis | Berenberg |
Marcus Bellander | Carnegie Investment Bank AB |